![Jane Grogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jane Grogan
Chief Tech/Sci/R&D Officer at
BIOGEN INC.
Net worth: 876 771 $ as of 2026-06-29
Profile
Jane Grogan is Executive Vice President & Head-Research at Biogen, Inc. since 2023.
Former roles include Chief Scientific Officer at Graphite Bio, Inc. from 2021 to 2023, Chief Scientific Officer at Arsenal Biosciences, Inc. from 2019 to 2021, and Head-Adaptive Tumor Immunity & Principal Scientist at Genentech, Inc. from 2014 to 2019.
Education includes an undergraduate degree from the University of Melbourne and a doctorate from the University of Leiden.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-12 | 4,058 ( 0% ) | 876 771 $ | 2026-06-29 |
Jane Grogan active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Chief Tech/Sci/R&D Officer | 2023-10-01 |
Former positions of Jane Grogan
| Companies | Position | End |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Chief Tech/Sci/R&D Officer | 2021-02-28 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2019-08-31 |
Training of Jane Grogan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technology Services |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
- Stock Market
- Insiders
- Jane Grogan
